The drugmaker's US business, which contributes over half its revenues, posted strong growth at Rs 2,323 crore compared with Rs 2,031 crore ...

Shares of Sun Pharma gained following the announcement of results, closing 2.09 per cent up at Rs 800.25 on the Bombay Stock Exchange.

You take Wockhardt, Ranbaxy, Strides Arcolab, all these companies, all these names have sort of a problem with the FDA.

Ranjit Kapadia an analyst at Centrum Broking doesn’t see more than 4-5 per cent revenue hit for the company due to import alert.

"Wockhardt has been languishing for some time now, whereas in case of Aurobindo, there is a steady flow of news on the launch of their gene...

Sun Pharma is the most valuable pharma stocks as the company is expected to post a strong performance in the quarters ahead.

Sun Pharma's scrip ended the day at Rs 583.50, up 2.62 pc on the BSE. In intra-day trade, the scrip jumped 3.2 pc to Rs 586.80 -- its 52-we...

Sun Pharmaceuticals hit an all-time high on hopes that the company will benefit after rival Janssen announced shortage of Doxil in US.

Elara Capital is of the view that current valuations of the company are rich and has maintained its ‘accumulate’ rating with target price o...

CLSA has maintained ‘buy’ rating on Sun Pharma with a price target of Rs 1220 per share, the Asian focused broker said in a report.

It is likely to report a net profit of Rs 922 crore for quarter ended March 2013, up 12 per cent, as compared to a net profit of Rs 820 cro...

The company logged 33% growth in its consolidated net sales and its operating profit margin stood at 44%.

Sun Pharmaceutical Industries today said it has received US health regulator's approval to market generic version of Doxil injection.

Shares of Sun Pharmaceutical Industries were in action in early trade after its Israel-based subsidiary reported better-than-expected resul...

After gaining market access under a USFDA contingency plan, Sun Pharma is awaiting approval for its cancer drug Lipodox.

Shares of Sun Pharma rose 4% on Wednesday after the US drug regulator said it will import generic version of the cancer drug Lipidox.

The US said it will import cancer drug manufactured in India to overcome the acute shortage of the medicine used in treatment of ovarian, b...